Herpes ZOSTER vaccine

Clinical Indication

All indications outside of the green book. Zostavax is a live vaccine, therefore NOT suitable for immunocompromised patients. Do not prescribe on FP10 (black through this route).

Comments

From 1st September 2023, Shingrix® will be offered to immunocompetent individuals routinely at 60 years of age, and to immunocompromised individuals aged 50 years old and over. Please see Green Book for further details.

Date of classification

June 2015

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.